Skip to main content
Equibles

MASSACHUSETTS FINANCIAL SERVICES CO /MA/

Position in ANIK — Anika Therapeutics, Inc.

CIK 912938 Boston, MA
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$1,049,819
-$32,156 QoQ
Shares Held
71,758
-3.8% QoQ
Ownership
0.536%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 134 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 83% Shared 17% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $152,241,305 across 13 Drug Manufacturers - Specialty & Generic names. ANIK ranks #9 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 COLL
Collegium Pharmaceutical, Inc
 1,405,567 $50,881,525
2 PBH
Prestige Consumer Healthcare Inc.
 629,836 $29,772,346
3 KNSA
Kiniksa Pharmaceuticals International, plc
 431,324 $27,583,169
4 NBIX
Neurocrine Biosciences Inc
 102,414 $17,260,854
5 HLN
Haleon plc
 957,121 $8,929,938
6 RDY
Dr Reddys Laboratories Ltd
 475,589 $6,891,283
7 INDV
Indivior Pharmaceuticals, Inc.
 144,366 $5,923,336
8 ZTS
Zoetis Inc.
 18,655 $1,340,547

All Filings in ANIK

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,049,819 71,758
2026-03-31 $1,081,975 74,619
2025-12-31 $445,691 46,378
2025-09-30 $450,362 47,911
2025-06-30 $473,571 44,761
2025-03-31 $664,431 44,207
2024-12-31 $744,205 45,213
2024-09-30 $1,150,130 46,564
2024-06-30 $1,208,013 47,691
2024-03-31 $1,170,686 46,090